Investor Resources

Resources for investors and interested parties

Delta4 is committed to creating revolutionary treatments to benefit patients with rare and complex diseases. That’s why we’ve made it our mission to use the latest technology to pursue drug discovery and drug repositioning.

Here you’ll find resources, such as videos, case studies, and detailed explanations, to help investors and interested parties better understand our approach to AI-driven drug discovery. Our team’s mission is to make sure that everyone has the information they need to understand the work we’re doing at Delta4.

Delta 4

Press Release

For the latest press releases and important industry events, check here to stay current with what we’re up to.
Delta team

Delta4 joins the EU-funded COST action PerMediK (Personalized medicine in chronic kidney disease: improved outcome based on Big Data)

The scientific aim of PerMediK is to support the development of a path towards personalized medicine in chronic kidney disease …

Read More →
Kurt Herpel, CEO of Delta4, and Revital Rattenbach, CEO of 4P-Pharma, celebrating the signature of a partnership agreement between Delta4 and 4P-Pharma in Paris (France).

4P-Pharma And Delta4 Join Forces To Find And Develop Treatments For A Rare Autoimmune Chronic Liver Disease

Paris (France) and Vienna (Austria), 31st May 2022 – 4P-Pharma, a French clinical-stage biotechnology company, and Delta4, an Austrian digital …

Read More →
clinical trial consultation

Delta4, in preparation for the first clinical study, focused on FSGS

Focal Segmental Glomerulosclerosis (FSGS) is a devastating clinical condition with defined glomerular histopathology and yet a multifaceted pathophysiological, histological and …

Read More →


Watch our videos to find out more about us and what we do.

Get Involved

Learn how you can contribute to the exciting work happening at Delta4


Forging the innovative treatments of the future requires brilliant minds and we’re always on the lookout for talent.


Contact us to find out more about how you can invest with us and be a part of pioneering the next successful treatment.

Medical Community

Learn how you can partner with us and combine our technology with your knowledge to develop treatments faster.